Wagner Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$828K Buy
4,460
+416
+10% +$77.2K 0.19% 60
2025
Q1
$847K Buy
4,044
+14
+0.3% +$2.93K 0.21% 54
2024
Q4
$716K Buy
4,030
+338
+9% +$60.1K 0.18% 59
2024
Q3
$729K Sell
3,692
-108
-3% -$21.3K 0.2% 55
2024
Q2
$652K Buy
3,800
+606
+19% +$104K 0.19% 59
2024
Q1
$582K Sell
3,194
-3,562
-53% -$649K 0.18% 67
2023
Q4
$1.05M Sell
6,756
-528
-7% -$81.8K 0.35% 49
2023
Q3
$1.09M Buy
7,284
+337
+5% +$50.2K 0.4% 47
2023
Q2
$936K Sell
6,947
-1,968
-22% -$265K 0.36% 52
2023
Q1
$1.42M Sell
8,915
-1,547
-15% -$247K 0.65% 43
2022
Q4
$1.69M Buy
10,462
+1,288
+14% +$208K 1.05% 27
2022
Q3
$1.23M Sell
9,174
-224
-2% -$30.1K 0.91% 28
2022
Q2
$1.44M Buy
9,398
+500
+6% +$76.6K 1.15% 24
2022
Q1
$1.44M Sell
8,898
-4,851
-35% -$787K 1.01% 21
2021
Q4
$1.86M Buy
13,749
+189
+1% +$25.6K 1.42% 16
2021
Q3
$1.56M Sell
13,560
-589
-4% -$67.5K 1.24% 20
2021
Q2
$1.59M Buy
14,149
+3,947
+39% +$445K 1.14% 20
2021
Q1
$1.1M Buy
10,202
+1,905
+23% +$206K 0.87% 28
2020
Q4
$889K Buy
+8,297
New +$889K 0.84% 36
2018
Q3
$152K Buy
1,606
+1
+0.1% +$95 0.1% 153
2018
Q2
$149K Buy
1,605
+38
+2% +$3.53K 0.11% 139
2018
Q1
$148K Buy
1,567
+16
+1% +$1.51K 0.11% 133
2017
Q4
$154K Buy
+1,551
New +$154K 0.12% 134